Year To Quarter End Consolidated Statement Of Income

COSMOS Pharmaceutical Corporation - Filing #7733875

Concept 2017-06-01 to
2017-08-31
2016-06-01 to
2016-08-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
138,726,000,000 JPY
126,578,000,000 JPY
Cost of sales
111,024,000,000 JPY
101,135,000,000 JPY
Gross profit (loss)
27,701,000,000 JPY
25,442,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
21,443,000,000 JPY
18,642,000,000 JPY
Operating profit (loss)
6,258,000,000 JPY
6,799,000,000 JPY
Non-operating income
Interest income
19,000,000 JPY
21,000,000 JPY
Non-operating income
814,000,000 JPY
707,000,000 JPY
Non-operating expenses
Interest expenses
23,000,000 JPY
25,000,000 JPY
Non-operating expenses
216,000,000 JPY
218,000,000 JPY
Ordinary profit (loss)
6,856,000,000 JPY
7,288,000,000 JPY
Extraordinary income
Extraordinary income
8,000,000 JPY
237,000,000 JPY
Extraordinary losses
Loss on disaster
JPY
47,000,000 JPY
Extraordinary losses
31,000,000 JPY
112,000,000 JPY
Profit (loss) before income taxes
6,834,000,000 JPY
7,413,000,000 JPY
Income taxes
2,195,000,000 JPY
2,799,000,000 JPY
Profit (loss)
4,638,000,000 JPY
4,614,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
4,638,000,000 JPY
4,614,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
0 JPY
-1,000,000 JPY
Remeasurements of defined benefit plans, net of tax
4,000,000 JPY
25,000,000 JPY
Other comprehensive income
4,000,000 JPY
24,000,000 JPY
Comprehensive income
4,643,000,000 JPY
4,639,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
4,643,000,000 JPY
4,639,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.